Resources
Home
/
Resources
-
Honing Analytical Methods for Next Generation ADCs
Speaker Presentation Wang Chunlei, AstraZeneca, 2024 -
Regulatory Considerations for Bioconjugates from the Small Molecule Perspective
Speaker Presentation Wan Kanny, CDER, FDA, 2024
-
Overview of the Landscape of Bioconjugates: Emerging Applications and Design Considerations
Speaker Presentation Ross-Holz Emily, Genentech, a Member of the Roche Group, 2024
-
CMC Regulatory Considerations for Antibody-Drug Conjugates
Speaker Presentation Morgan Charles, Denali Therapeutics, 2024
-
Antibody Drug Conjugates - Requirements for Characterization and Control of ADCs from a (European) Regulator's Perspective
Speaker Presentation Merz Christian, Paul-Ehrlich-Institut, 2024
-
Bioconjugates: Navigating the Regulatory Landscape
Speaker Presentation Jules Felix, Health Canada, 2024
-
Understanding Impurities in Antibody Conjugates
Speaker Presentation Jeffery Carroll, Avidity Biosciences, 2024
-
Control Strategies for Potency
Speaker Presentation James David, Merck & Co., Inc., 2024
-
Considerations for Developing Oligonucleotide Transport Vehicle Conjugates
Speaker Presentation Adams Amelia, Denali Therapeutics, 2024
-
CMC Strategy Forum North America July 2024 Scientific Program
Scientific Program: CMC Strategy Forum North America July 2024
-
Comparability for Cell and Gene Therapy Products
Summary Paper: CGTP Summit 2023
-
Plenary Session 4 - Potency Assays for Gene Edited Products Summary
Speaker Presentation Pannullo Nicole Plenary Session 4 Summary 2024 -
Plenary Session 4 – Potency Assays for Gene Edited Products Summary
Speaker Presentation Cannon Alkeiver Plenary Session 4 Summary 2024
-
Gene Therapy Product Analytics: Potency Method Validation and Optimization
Speaker Presentation Zhang Wandong, BioMarin Pharmaceutical Inc., 2024
-
PMDA’s Vision in New (Fifth) Mid-term Targets-International Vision
Speaker Presentation Maruyama Yoshiaki, PMDA, 2024
-
Approaches to Potency Assays for CRISPR Genome Editing Therapeutics
Speaker Presentation Wood Kristy, Intellia Therapeutics, Inc., 2024
-
Overview of Current Genomic Analytical Tools to Enable Advancement of Investigational in vivo Genome Editing Products into Clinical Studies
Speaker Presentation Seitzer Jessica, Intellia Therapeutics, Inc., 2024
-
Balancing Flexibility and Standardization of AAV Manufacturing Processes
Speaker Presentation Segura Gally Mercedes, ElevateBio, 2024
-
EU Regulatory Update
Speaker Presentation Reischl Ilona, AGES BASG, 2024
-
Cellular Engineering to Address Manufacturing and Regulatory Concerns
Speaker Presentation McDevitt Todd, Genentech, a Member of the Roche Group, 2024